TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biomérieux Sweden AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
225,811
|
219,959
|
207,929 |
| Financial expenses |
38
|
4
|
378 |
| Earnings before taxes |
6,054
|
3,650
|
2,712 |
| EBITDA |
7,430
|
4,716
|
5,040 |
| Total assets |
89,215
|
91,207
|
81,044 |
| Current assets |
82,771
|
83,630
|
72,274 |
| Current liabilities |
60,661
|
57,246
|
45,287 |
| Equity capital |
9,562
|
15,940
|
20,264 |
| - share capital |
325
|
336
|
334 |
| Employees (average) |
34
|
31
|
27 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
10.7%
|
17.5%
|
25.0% |
| Turnover per employee |
6,642
|
7,095
|
7,701 |
| Profit as a percentage of turnover |
2.7%
|
1.7%
|
1.3% |
| Return on assets (ROA) |
6.8%
|
4.0%
|
3.8% |
| Current ratio |
136.4%
|
146.1%
|
159.6% |
| Return on equity (ROE) |
63.3%
|
22.9%
|
13.4% |
| Change turnover |
13,127
|
10,959
|
-11,281 |
| Change turnover % |
6%
|
5%
|
-5% |
| Chg. No. of employees |
3
|
4
|
0 |
| Chg. No. of employees % |
10%
|
15%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.